Can amiodarone (Amloyd) cause hypothermia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amiodarone and Hypothermia

Amiodarone (Amloyd) does not directly cause hypothermia as a known adverse effect, but it can interact with hypothermic conditions during cardiac arrest management and resuscitation. 1

Known Adverse Effects of Amiodarone

Amiodarone has numerous documented adverse effects, but hypothermia is not among them:

  • Pulmonary toxicity: The most serious adverse effect, presenting as subacute cough and progressive dyspnea 1
  • Thyroid dysfunction: Both hypothyroidism (more common) and hyperthyroidism can occur 1
  • Liver toxicity: Manifested by elevated liver transaminases 1
  • Neurologic effects: Including ataxia, paresthesias, tremor, and peripheral neuropathy 1
  • Cardiovascular effects: Bradycardia, heart block, QT prolongation 1, 2
  • Dermatologic effects: Photosensitivity and bluish skin discoloration 1
  • Ocular effects: Corneal microdeposits, optic neuropathy 1
  • Gastrointestinal effects: Nausea, anorexia, constipation 1
  • Hypotension: Particularly with intravenous administration 3

Amiodarone and Therapeutic Hypothermia

While amiodarone does not cause hypothermia, there are important interactions to consider when using amiodarone in patients undergoing therapeutic hypothermia:

  • Therapeutic hypothermia prolongs the QT interval, and amiodarone can further prolong QT, potentially increasing arrhythmia risk 4
  • In experimental models, amiodarone combined with hypothermia has shown:
    • Increased dispersion of repolarization during ischemia 5
    • Slowed conduction velocity during ischemia 5
    • Abolished beneficial effects of therapeutic hypothermia on ischemia-induced parameters 5

Clinical Implications

  • For cardiac arrest management: When using amiodarone during therapeutic hypothermia, be aware that:

    • Amiodarone may suppress rearrest caused by ventricular fibrillation but not pulseless electrical activity 5
    • The hypothermic heart may have altered response to cardiovascular drugs including amiodarone 1
    • Drug metabolism may be reduced in hypothermia, with theoretical concern for medication accumulation 1
  • For monitoring: When using amiodarone in hypothermic patients:

    • Monitor QTc interval closely as both conditions can prolong it 4
    • Be vigilant for hypotension, which can be sustained throughout amiodarone infusion 3
    • Consider that amiodarone may interact with anesthetic agents to produce hypotension and atropine-resistant bradycardia 6

Conclusion

Amiodarone does not cause hypothermia as a direct adverse effect. However, when used in patients with hypothermia (accidental or therapeutic), there are important interactions to consider regarding cardiac electrophysiology, drug metabolism, and hemodynamic effects that require careful monitoring and management.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amiodarone Contraindications and Precautions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

QTc prolongation during therapeutic hypothermia: are we giving it the attention it deserves?

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2010

Research

Drug interactions with amiodarone.

American heart journal, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.